Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001846344-21-000001
Filing Date
2021-02-16
Accepted
2021-02-16 13:03:21
Documents
1
Effectiveness Date
2021-02-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7456
  Complete submission text file 0001846344-21-000001.txt   8521
Mailing Address 10210 CAMPUS POINT DRIVE #150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE #150 SAN DIEGO CA 92121 619-786-7702
Replicate Bioscience, Inc. (Filer) CIK: 0001846344 (see all company filings)

EIN.: 861495974 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-389517 | Film No.: 21635311